Abstract: Bone marrow-derived mesenchymal stem cells (BMSCs) have considerable potential for self-renewal and multi-differentiation. Tumor necrosis factor-α (TNF-α) is an inflammatory cytokine and is involved in tissue regeneration during wound healing. It was already reported that cultured human dental pulp cells acquire stem cell properties following short-term stimulation by TNF-α. However, it has not been clarified if BMSCs acquire stem cell properties after TNF-α treatment. The purpose of this study was to investigate the effect of short-term stimulation with TNF-α on BMSCs. Rat BMSCs were cultured up to 60% confluence and then incubated with 1-100 ng/ml of recombinant rat TNF-α (rTNF-α) for a further 2 days. After reaching subconfluence, cells were passaged once to remove rTNF-α completely before subsequent assays. Cells in the control group were passaged without stimulation. Expression levels of Nanog and Oct4 stem cell markers were significantly increased in the rTNF-α 10 ng/ml stimulation group. rTNF-α stimulation did not affect cell proliferation compared with the control group. However, rTNF-α stimulation led to a delay in cell differentiation. This study suggests that short-term TNF-α stimulation of BMSCs significantly increased their stem cell phenotype, but delayed their osteogenic cell differentiation.
Introduction
Current advances in regenerative medicine are founded on many previous studies in embryonic development, stem cell biology and tissue engineering technology [1] [2] [3] . The generation of stem cells from different sources, such as tissue-derived stem cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, is an attractive concept in regenerative medicine 4, 5) . Many studies using stem cells have attempted to regenerate damaged tissues and organs that have structural and functional disorders 6, 7) . The issue of immunological rejection of transplanted cells or tissues would ideally be prevented by autologous transplantation. Therefore, utilizing stem cells derived from patients is currently the first choice in regenerative medicine 8) . Bone marrow-derived mesenchymal stem cells (BMSCs), which can be collected from patients and easily cultured in the laboratory, have a considerable potential for self-renewal and multi-differentiation into various functional cells 9, 10) .
The use of BMSCs in applications such as the treatment of severe burn injury, bone regeneration and myocardial reproduction, has featured in human clinical trials 9, 11, 12) . Hence, BMSCs are widely expected to play an important part in the future of regenerative medicine. When considering the use of stem cell transplantation and tissue engineering technology, a key factor is the number of mesenchymal stem cells as this greatly affects the success rate of tissue regeneration and refunctionalization 13, 14) . There are very few cells with a stem cell phenotype from among the population of BMSCs collected from bone marrow 15) . It has been reported that the number and functionality of the stem cell population in bone marrow decreases in an age-dependent manner 16) . Therefore, elderly patients, who may need regenerative medicine, are likely to have only a small number of stem cells and a reduced stem cell activity 17) . Furthermore, mesenchymal stem cells can easily decrease their stem cell functionality during in vitro cell culture 18) . It is therefore difficult to obtain a large amount of stem cells for transplantation and other applications 19) . A novel culture method for maintaining/improving stem cell properties in vitro could therefore make regenerative technology available for elderly patients. One regenerative technique employs the application of growth factors and cytokines to in vitro stem/progenitor cell cultures that contributes to cellular activation resulting in cell growth and cell differentiation 20, 21) . This technique is often adopted to differentiate undifferentiated stem cells, including mesenchymal stem cells or pluripotent stem (ES/ iPS) cells 22) . Cell culture technology using various cytokines has also been developed to maintain the cellular properties and characteristics of stem cells 23, 24) . However, there is no culture method whereby stem cell functionality is obtained from cells degenerated as a result of aging, disease and injury 25) . Tumor necrosis factor-α (TNF-α) induces a range of biological phenomena, such as bone resorption, joint destruction, swelling and edema, through the action of inflammatory responses 26, 27) . However, it is suggested that TNF-α plays a role in tissue regeneration through the induction of other cytokines found in the wound healing process 28, 29) . Although cultured human dental pulp cells acquire stem cell
properties following short-term stimulation with TNF-α 30) , it is not known if BMSCs acquire stem cell properties after treatment with TNF-α. BMSCs were cultured up to 60% confluence, following which, they were exposed to 1-100 ng/ml of recombinant rat TNF-α for 2 days. BMSCs were then passaged once to remove the rTNF-α completely before subsequent assays. In this study, we demonstrated that in rat BMSCs, TNF-α treatment affected the acquisition of stem cell properties. Short-term stimulation with TNF-α in cultured cells accelerated the upregulation of stem cell markers and increased the stem cell phenotype of BMSCs. This novel cell culture method may have the potential in future to aid in the rejuvenation of degraded stem cells derived from elderly patients.
Materials and Methods

Cell culture
BMSCs were collected from five to six-week-old Sprague Dawley rats. The femur and tibia were harvested, then the epiphysis of the bones were cut off, and the bone marrow cavity was flushed with culture medium, as defined below, using a 23 gauge needle with 5 ml syringe. The resulting whole bone marrow suspension was mixed well and filtered through a 70 µm cell strainer (BD Falcon, Franklin Lakes, NJ, USA) to obtain BMSCs. The cells were cultured with basal medium consisting of alpha-minimum essential medium (α-MEM) (Nacalai Tesque Inc., Kyoto Japan), 10% heat inactivated fetal bovine serum (FBS) (Thermo Fisher Scientific, MA, USA) and 1% penicillin and streptomycin (Nacalai Tesque Inc.), at 37°C under 5% CO 2 in air.
BMSCs were cultured to 60% confluence and incubated with 1-100 ng/ml of recombinant rat TNF-α (rTNF-α) (R&D Systems Inc., MN, USA) for 2 days. Before reaching confluence, cells were passaged once using accutase (Nacalai Tesque Inc.) to remove rTNF-α completely before subsequent assays (Fig. 1a) . Cells were examined using light microscopy (Nikon Eclipse TS100, Tokyo, Japan). All of the animal procedures were approved by the Board for Animal Experiments at Tokushima University (Admission Number: T27-79).
Induction of differentiation
BMSCs were cultured up to subconfluence and induced to differentiate into osteoblasts, chondrocytes, neurons and adipocytes using a specific induction medium as detailed below.
To analyze the osteogenic differentiation potential, cells were cultured in osteogenic induction medium containing α-MEM, 10% FBS, 0.01 µM dexamethasone (Sigma-Aldrich Co., Tokyo, Japan), ß-glycerophosphate (Nacalai Tesque Inc.), 0.1 mM L-ascorbic acid-2-phosphate and 1% penicillin-streptomycin solution (Nacalai Tesque Inc.).
For chondrogenic differentiation, cells were cultured in chondrocyte induction medium containing high-glucose DMEM (Nacalai Tesque Inc.), 10% FBS, 1% insulin-transferring selenium (Corning, NY, USA), 0.1 µM dexamethasone, 40 µg/ml L-proline (Nacalai Tesque Inc.), 50 µg/ml L-ascorbic acid-2-phosphate, 1 mM sodium pyruvate (Sigma-Aldrich Co.) and 1% penicillin-streptomycin solution.
To evaluate the neurogenic differentiation ability, cells were cultured with pre-induction medium consisting of DMEM low-glucose medium (Nacalai Tesque Inc.) supplemented with 10% FBS, 10 ng/ml epithelium growth factor (EGF) (PeproTech, London, UK), 20 ng/ml basic fibroblast growth factor (bFGF) (PeproTech) and 10 ng/ml brain derived neurotrophic factor (BDNF) (R&D Systems Inc.) for 3 days. After pre-induction, the cells were induced for 4 days in neurogenic medium consisting of DMEM low-glucose medium, 10% FBS, 120 µM indomethacin (Nacalai Tesque Inc.), 3 µg/ml insulin (Sigma-Aldrich Co.) and 300 µM isobutyl-methylxanthine (Nacalai Tesque Inc.).
To evaluate the adipogenic differentiation ability, cells were cultured in adipocyte induction medium. Medium for adipocyte differentiation contained α-MEM, 10% FBS, 0.5 mM 3-isobytyl-1-methylxanthine (Nacalai Tesque Inc.), 60 µM indomethacin (Nacalai Tesque Inc.), 1 µg/ ml insulin, 2 mM L-glutamine (Thermo Fisher Scientific), 0.1 mM L-ascorbic acid-2-phosphate and 1% penicillin-streptomycin solution.
Quantitative real-time polymerase chain reaction (PCR)
BMSCs were cultured under each condition for 7 days and total RNA extracted using TRIzol (Life Technologies, CA, USA). The final quantity and concentration of total RNA was calculated with a spectrophotometer (NanoDrop® ND-1000, Nanodrop Technologies, Inc., DE, USA) at 260 nm. RNase-free DNase I (Invitrogen, Thermo Fisher Scientific, CA, USA) was utilized to remove any DNA contaminants from the purified total RNA. The cDNA was synthesized from 1 µg of total RNA using a High Capacity RNA-to-cDNA Kit (Applied Biosystems, CA, USA). Quantitative real-time PCR was performed by Step One Plus (Applied Biosystems) using the primers for the following genes Octamer-binding transcription factor 4 (Oct4), Nanog, Osteocalcin (Ocn), Runt-related transcription factor 2 (Runx2), Collagen type II alpha 1 chain (Col2a1), Aggrecan, Glial fibrillary acidic protein (Gfap), Neuron-specific class III beta-tubulin (Tuj1), Adipocyte protein 2 (Ap2), Peroxisome proliferator-activated receptor ɤ (Ppar-ɤ) genes, and ß-actin as shown (Table 1 ). The thermal cycle conditions consisted of an initial denaturation step at 94°C for 3 min, 40 cycles of amplification at 94°C for 30 s, 60°C for 30 s and 72°C for 1 min. The specificity of PCR products was calculated using melting curve analysis at the end of the PCR cycles. The reaction products were quantified by standard curves generated from serial dilutions of each sequence at a known concentration. The mRNA content of each target was normalized to the values of ß-actin mRNA in each sample. 
Immunofluorescence staining
After 7 days of BMSC culture, the expression of NANOG and OCT4 proteins was detected using immunofluorescence. The cells were fixed in 4% paraformaldehyde (PFA) for 10 min, washed three times with phosphate buffered saline (PBS), permeabilized in PBS with 0.2% Triton X-100 for 45 min and blocked with 5% horse serum in PBS. After washing with PBS, the cells were incubated with primary antibodies at 4°C overnight, and then incubated with secondary antibodies at room temperature for 45 min in the dark. The NANOG primary antibody (1:100, Abcam, Cambridge, MA, USA) was followed by an Alexa Fluor® 488 goat anti-mono IgG3 (ɤ3) (1:500, Invitrogen) secondary antibody, and the OCT4 primary antibody (1:100, Abcam) was followed by a goat polyclonal antibody to rabbit IgG Alexa Fluor® 488 (1:1000, Abcam). Cell nuclei were then stained with 4′6-diamidino-2-phenylindole (DAPI; NucBlue™ Fixed Cell Stain ReadyProbes, Invitrogen). Immunofluorescence staining was observed using a fluorescence microscope (Nikon Eclipse TE2000-U, Tokyo, Japan). The number of positive cells were counted per unit area, and compared between control group and rTNF-α (10 ng/ml) stimulation group.
Colony Forming Unit Fibroblast assay (CFU-F assay)
The CFU-F assay was performed to evaluate colony-forming ability. BMSCs were seeded in 25 cm 2 flasks (BD Falcon) at a density of 100 cells/flask and cultured for 2 weeks. Cells were fixed with 4% PFA and stained with toluidine blue. Colonies with more than 50 cells were counted and the average value calculated in 5 flasks per condition.
MTS assay
Cell proliferation was assessed at days 1, 3, 5, and 7 by the MTS (3-(4,5-dimethylthiazol-2-yl) -5-(3-carboxymethoxyphenyl) -2-(4-sulfophenyl) -2H-tetrazolium) assay (CellTiter 96® Aqueous One Solution Cell Proliferation Assay, Promega, WI, USA). After aspirating the medium, cells were incubated in the mixed solution containing α-MEM medium and CellTiter 96® Aqueous One Solution Reagent in the ratio of 5:1 for 1 hour in a 5% CO 2 atmosphere at 37°C. Supernatant was transferred into a 96-well plate, and read by a plate reader at a wavelength of 492 nm.
Detection of apoptotic cells
Apoptotic cells were detected using the TdT-mediated dUTP nick end labeling method (Apoptosis in situ Detection Kit Wako, Wako, Osaka, Japan) in accordance with the manufacturer's protocol. Experiments were carried out using cells 2 days after rTNF-α stimulation and 3 days after cell passage. The percentage of apoptotic cells were calculated per unit area and then compared for each concentration.
Determination of alkaline phosphatase activity
Alkaline phosphatase activity was measured on days 3, 5, and 7 by 
Alizalin red staining
Alizarin red staining was performed to determine calcification. Cells were washed with PBS and stained with 1% alizarin red solution (Muto Pure Chemicals Co., Tokyo, Japan) for 10 minutes. The culture plates were washed three times with distilled water. The calcification was observed using light microscopy.
Statistical analysis
Statistical differences between groups were determined by the Student's t-test or one-way analysis of variance (ANOVA) with a post hoc test (Bonferroni) using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan). EZR is a modified version of R (The R Foundation for Statistical Computing, Vienna, Austria) designed to calculate statistical functions frequently used in biostatistics. The Student's t-test was used to analyze: the number of cells with positive immunofluorescence, the CFU-F assay, and quantitative real time PCR of Ocn, Runx2, Col2a1, Aggrecan, Gfap, Tuj1, Ap2, Ppar-ɤ. One way ANOVA was utilized for quantitative real time PCR of Nanog and Oct4, the MTS assay, the ALP assay and apoptosis analysis. P values of less than 0.05 were considered to be statistically significant.
Results
BMSCs acquire stem cell properties after rTNF-α treatment
Expression levels of Nanog and Oct4 stem cell markers were examined by quantitative real-time RT-PCR and immunofluorescence staining. Quantitative real-time PCR showed that expression levels of Nanog and Oct4 significantly increased in the rTNF-α 10 ng/ml stimulation group compared with the control group (Fig. 1b) . Immunofluorescence staining showed that the ratio of NANOG and OCT4 positive cells increased in the rTNF-α 10 ng/ml stimulation group. There was also a significant increase in the number of positive cells per unit area in the rT-NF-α 10 ng/ml stimulation group as compared with the control group (Fig. 1c, d ). This suggests that BMSCs treated with rTNF-α acquired stem cell properties and that 10 ng/ml rTNF-α is the optimal concentration to stimulate BMSCs.
The effect of rTNF-α on the morphology and proliferative ability of BMSCs
BMSCs were observed by light microscopy. There was no difference in cell morphology between the control group and the rTNF-α 10 ng/ml stimulated group (Fig. 2a) . Colony-forming ability was evaluated by the CFU-F assay. Stem cells were able to form colonies, and there was no difference in colony-forming ability between BMSCs from the control group and from the rTNF-α 10 ng/ml stimulation group (Fig. 2b) . Cell proliferation was analyzed by the MTS assay on days 1, 3, 5, and 7. There was no significant difference in cell proliferation between the rT-NF-α stimulated (1 ng/ml, 10 ng/ml) and the control groups on days 1, 3, 5, and 7. However, cell proliferation was significantly inhibited by higher concentrations of rTNF-α stimulation, such as 50 ng/ml and 100 ng/ml, as compared with the other three groups on days 3, 5 and 7 (Fig.  2c) . TNF-α treatment is reported to induce apoptosis. Apoptotic cells were detected by the TUNEL method and the ratio of apoptotic cells was examined. In BMSCs stimulated with rTNF-α, but before cell passage, the ratio of apoptotic cells was significantly increased in the rT-NF-α 50 ng/ml and 100 ng/ml groups as compared with the other three groups. However, in BMSCs after three days of cell passage, there was no significant difference between groups (Fig. 2d) . These findings suggest that stimulation of rTNF-α 10 ng/ml did not affect cell behavior in terms of morphology and proliferative ability.
Examination of BMSC multipotency after rTNF-α stimulation
Quantitative real-time PCR was performed to examine the multipotency of BMSCs following TNF-α stimulation. Ocn and Runx2 were used as marker genes for osteogenic differentiation. Quantitative real-time PCR showed that expression levels of Ocn and Runx2 were significantly decreased in the rTNF-α 10 ng/ml stimulated group compared with the control group (Fig. 3a) . Col2a1 and Aggrecan were used as markers of chondrocyte differentiation and their expression levels were significantly decreased in the rTNF-α 10 ng/ml stimulated group compared with the control group (Fig. 3b) . Expression levels Gfap and Tuj1, markers of neural differentiation, were significantly decreased in the rT-NF-α 10 ng/ml stimulated group compared with the control group (Fig.  3c) . However, there was no significant difference in the expression levels of adipocyte differentiation markers Ap2 and Ppar-ɤ between the control groups and rTNF-α 10 ng/ml stimulated group (Fig. 3d) .
rTNF-α stimulation delayed osteogenic differentiation
After short-term stimulation of BMSCs by rTNF-α, there was a decrease in the degree of differentiation. Therefore, we investigated the effect of long-term rTNF-α stimulation on differentiation of BMSCs. Osteogenic differentiation was investigated by analyzing ALP activity and alizarin red staining. Significantly higher levels of ALP activity were shown on days 5 and 7 in the control group compared with the stimulation group (Fig. 4a) . Alizarin red staining showed that there was a decrease in the formation of calcified nodules in the stimulated group compared with the control group up until day 21. However, the formation of calcified nodules in the stimulated group had recovered to the same level as the control group by 28 days (Fig. 4b) .
These findings suggest that short-term stimulation of rTNF-α may cause delayed differentiation of BMSCs. Discussion TNF-α, one of the inflammatory cytokines, plays an important role in tissue repair during the wound healing process 29) . TNF-α promotes bone regeneration through the mediation of early bone remodeling at bone fracture sites 28) . Although the use of high concentrations of TNF-α inhibits bone healing, there is an optimal concentration of TNF-α stimulation for tissue repair 31, 32) . In addition, an in vitro study demonstrated that short-term stimulation of TNF-α increased the stem cell population of dental pulp cells 30) . In this study, we found that short-term stimulation with TNF-α significantly promoted the stem cell phenotype of BMSCs by increasing the gene expression of stem cell markers and the number of positive cells. Our study showed that 10 ng/ml TNF-α stimulation was the optimal concentration for increasing the stem cell population of BMSCs. Furthermore, our culture method did not affect cell morphology, cell proliferation or survival. These findings indicate that short-term stimulation of BMSCs by TNF-α potentially leads to the acquisition of stem cell properties.
The same study on TNF-α-stimulated dental pulp cells reported that the cells increased their ability to differentiate into different cell types such as those in osteogenic and adipogenic pathways 30) . In this study, we showed that TNF-α stimulation significantly decreased the ability of TNF-α treated BMSCs to differentiate into osteogenic, cartilaginous and neural pathways, but not adipogenic ones. In long-term osteogenic induction, TNF-α treated BMSCs gradually produced mineralized nod-ules, and there were no differences in the mineralized nodule formation compared with non-treated BMSCs by the 28th day of osteogenic induction. Several studies have reported that TNF-α inhibited Type I collagen production and ALP expression based on the blockage of osteoblast differentiation in osteoblastic clonal cell lines [33] [34] [35] . Furthermore, Inoue et al. have shown that short-term stimulation by TNF-α delayed cell differentiation in osteoblast-like cells 36) . In this study of a heterogeneous BMSC population, it is not clear if there are different bone marrow subpopulations that acquire stem cell properties after TNF-α stimulation 37) .
Further studies are needed to investigate the reactivity of each cell type within bone marrow when applying this culture method for use in regenerative medicine.
In the clinic patients may expect the provision of stem cell-based regenerative medicine for tissue repair and functional recovery 6) . However, these patients, especially elderly patients, may have a small number of stem cells with low stem cell functionality, and it may therefore difficult to prepare a sufficient amount of stem cells for regenerative medicine 17) . Recently, iPS cells have been proposed as a source of cells that can differentiate into target stem cells. However, there are many problems, such as risk of tumor formation and a complex culturing process, that may rule out their practical use 38, 39) . The current cell culture technologies for maintaining cellular properties have established using various cytokines and matrix coating materials 23, 24) . However, the culture method for acquiring stem cell properties from degenerated and senescent cells has not been yet developed 25) . This study developed a novel culture method using short-term TNF-α stimulation that resulted in the acquisition of stem cell properties in vitro. Our cell culture technology provides a simple and safe method for effective stem cell culture that could be useful for making regenerative medicine available for elderly patients.
In conclusion, this study shows that short-term TNF-α stimulation significantly increases the stem cell phenotype of BMSCs, but that osteogenic cell differentiation may be delayed in TNF-α treated BMSCs.
